John Spencer

Optimization of 1,3,4-benzotriazepine-based CCK(2) antagonists to obtain potent, orally active inhibitors of gastrin-mediated gastric acid secretion.

J. Black, D. Sykes, I. Buck, 2007, Journal of medicinal chemistry.

Achiral, selective CCK2 receptor antagonists based on a 1,3,5-benzotriazepine-2,4-dione template.

Eric Griffin, I. M. Mcdonald, I. Linney, 2008, Bioorganic & medicinal chemistry.

Generation of ligand conformations in continuum solvent consistent with protein active site topology: application to thrombin.

Jörg Weiser, Paulette A Greenidge, M. Scully, 2003, Journal of medicinal chemistry.